These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12465769)

  • 1. Treatment of fibroadenomatous hyperplasia in cats with aglépristone.
    Görlinger S; Kooistra HS; van den Broek A; Okkens AC
    J Vet Intern Med; 2002; 16(6):710-3. PubMed ID: 12465769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of feline mammary fibroadenomatous hyperplasia with a progesterone-antagonist.
    Wehrend A; Hospes R; Gruber AD
    Vet Rec; 2001 Mar; 148(11):346-7. PubMed ID: 11316295
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of fibroadenomatosis in 14 cats with aglepristone - changes in blood parameters and follow-up.
    Jurka P; Max A
    Vet Rec; 2009 Nov; 165(22):657-60. PubMed ID: 19946126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is your diagnosis? Feline mammary fibroepithelial hyperplasia.
    Sontas BH; Turna O; Ucmak M; Ekici H
    J Small Anim Pract; 2008 Oct; 49(10):545-7. PubMed ID: 18844825
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of mastitis and abscessation of mammary glands secondary to fibroadenomatous hyperplasia in a primiparturient cat.
    Burstyn U
    J Am Vet Med Assoc; 2010 Feb; 236(3):326-9. PubMed ID: 20113246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of fibroepithelial hyperplasia (FEH) of the mammary gland in the cat with the progesterone antagonist Aglépristone (Alizine)].
    Meisl D; Hubler M; Arnold S
    Schweiz Arch Tierheilkd; 2003 Mar; 145(3):130-6. PubMed ID: 12677773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammary fibroadenomatous hyperplasia in a young cat attributed to treatment with megestrol acetate.
    MacDougall LD
    Can Vet J; 2003 Mar; 44(3):227-9. PubMed ID: 12677692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up examinations after medical treatment of pyometra in cats with the progesterone-antagonist aglepristone.
    Nak D; Nak Y; Tuna B
    J Feline Med Surg; 2009 Jun; 11(6):499-502. PubMed ID: 19097817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative treatments for feline fibroadenomatous changes of the mammary gland.
    Marino G; Pugliese M; Pecchia F; Garufi G; Lupo V; Di Giorgio S; Sfacteria A
    Open Vet J; 2021; 11(4):680-685. PubMed ID: 35070864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mid-gestation pregnancy termination by the progesterone antagonist aglepristone in queens.
    Georgiev P; Wehrend A
    Theriogenology; 2006 Apr; 65(7):1401-6. PubMed ID: 16198402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, biological and hormonal study of mid-pregnancy termination in cats with aglepristone.
    Fieni F; Martal J; Marnet PG; Siliart B; Guittot F
    Theriogenology; 2006 Oct; 66(6-7):1721-8. PubMed ID: 16563487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological changes of the feline cervix, endometrium and placenta after mid-gestational termination of pregnancy with aglepristone.
    Georgiev P; Wehrend A; Penchev G; Vodenicharov A; Kauffold J; Leiser R
    Reprod Domest Anim; 2008 Aug; 43(4):409-14. PubMed ID: 18298407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of abortion with aglepristone in cats on day 45 and 46 after mating.
    Georgiev P; Bostedt H; Goericke-Pesch S; Dimitrov M; Petkov P; Stojanthev K; Tsoneva V; Wehrend A
    Reprod Domest Anim; 2010 Oct; 45(5):e161-7. PubMed ID: 19961554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aglepristone: A review on its clinical use in animals.
    Gogny A; Fiéni F
    Theriogenology; 2016 Mar; 85(4):555-66. PubMed ID: 26525399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of ovariohysterectomy on feline mammary fibroepithelial hyperplasia treatment.
    de Melo EH; Câmara DR; Notomi MK; Jabour FF; Garrido RA; Nogueira AC; Júnior JC; de Souza FW
    J Feline Med Surg; 2021 Apr; 23(4):351-356. PubMed ID: 32812465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone receptor isoform A may regulate the effects of neoadjuvant aglepristone in canine mammary carcinoma.
    Guil-Luna S; Stenvang J; Brünner N; De Andrés FJ; Rollón E; Domingo V; Sánchez-Céspedes R; Millán Y; Martín de Las Mulas J
    BMC Vet Res; 2014 Dec; 10():296. PubMed ID: 25515784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of pregnancy in cats using aglepristone on days 5 and 6 after mating.
    Goericke-Pesch S; Georgiev P; Wehrend A
    Theriogenology; 2010 Jul; 74(2):304-10. PubMed ID: 20451994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammary fibroadenomatous hyperplasia in a male cat.
    Mayayo SL; Bo S; Pisu MC
    JFMS Open Rep; 2018; 4(1):2055116918760155. PubMed ID: 29568542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the anti-progestin aglepristone on the uterine tissue of cats administered medroxyprogesterone acetate.
    Muphung W; Rungsipipat A; Chatdarong K
    Reprod Domest Anim; 2009 Jul; 44 Suppl 2():204-7. PubMed ID: 19754569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aglépristone, a progesterone receptor antagonist, administered during the early luteal phase in non-pregnant bitches.
    Galac S; Kooistra HS; Dieleman SJ; Cestnik V; Okkens AC
    Theriogenology; 2004 Aug; 62(3-4):494-500. PubMed ID: 15226005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.